EP2240191A4 - COMPOSITION COMPRISING LYSIMACHIA CLETHROID EXTRACTS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES - Google Patents

COMPOSITION COMPRISING LYSIMACHIA CLETHROID EXTRACTS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

Info

Publication number
EP2240191A4
EP2240191A4 EP08870585A EP08870585A EP2240191A4 EP 2240191 A4 EP2240191 A4 EP 2240191A4 EP 08870585 A EP08870585 A EP 08870585A EP 08870585 A EP08870585 A EP 08870585A EP 2240191 A4 EP2240191 A4 EP 2240191A4
Authority
EP
European Patent Office
Prior art keywords
clethroid
lysimachia
extracts
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08870585A
Other languages
German (de)
French (fr)
Other versions
EP2240191A2 (en
Inventor
Min-Ho Oak
Jung-Ok Lee
Woon-Sun Choi
Jung-Duk Sohn
Jong-Hoon Kim
Jee Woong Lim
Chung Keun Rhee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yang Ji Chemical Co Ltd
HAN WHA PHARMA CO Ltd
Original Assignee
Yang Ji Chemical Co Ltd
HAN WHA PHARMA CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yang Ji Chemical Co Ltd, HAN WHA PHARMA CO Ltd filed Critical Yang Ji Chemical Co Ltd
Publication of EP2240191A2 publication Critical patent/EP2240191A2/en
Publication of EP2240191A4 publication Critical patent/EP2240191A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/35Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP08870585A 2008-01-18 2008-12-17 COMPOSITION COMPRISING LYSIMACHIA CLETHROID EXTRACTS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES Withdrawn EP2240191A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080005782A KR100948332B1 (en) 2008-01-18 2008-01-18 Composition for the prevention and treatment of cardiovascular diseases, including the magpie swimming extract
PCT/KR2008/007485 WO2009091121A2 (en) 2008-01-18 2008-12-17 Composition comprising the extracts of lysimachia clethroides for prevention and treatment of cardiovascular diseases

Publications (2)

Publication Number Publication Date
EP2240191A2 EP2240191A2 (en) 2010-10-20
EP2240191A4 true EP2240191A4 (en) 2011-04-13

Family

ID=40885751

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08870585A Withdrawn EP2240191A4 (en) 2008-01-18 2008-12-17 COMPOSITION COMPRISING LYSIMACHIA CLETHROID EXTRACTS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

Country Status (4)

Country Link
EP (1) EP2240191A4 (en)
KR (1) KR100948332B1 (en)
CN (1) CN101969969A (en)
WO (1) WO2009091121A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100989093B1 (en) 2008-01-18 2010-10-25 한화제약주식회사 Composition for the prevention and treatment of cardiovascular diseases comprising extract of ginger tree branches
KR101168566B1 (en) 2010-05-20 2012-07-27 재단법인 제주테크노파크 Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea
KR102014824B1 (en) 2018-05-09 2019-08-28 주식회사 진생바이팜 Health food composition for vascular relaxation and anti-thrombotic effects comprising Black Ginseng Radix, Salviae Miltiorrhizae Radix, Leonuri Herba and Cnidii Rhizoma
CN110419741A (en) * 2018-08-07 2019-11-08 湖南炎帝生物工程有限公司 Nostoc composition and its application in improvement diarrhea, mitigation intestinal inflammatory
WO2023128540A1 (en) * 2021-12-31 2023-07-06 한국 한의학 연구원 Composition for preventing, ameliorating, or treating metabolic diseases, containing extract of lysimachia mauritiana as active ingredient
KR20260005688A (en) 2024-07-03 2026-01-12 대한민국(기후에너지환경부 국립생물자원관장) Composition containing extract of Lysimachia clerthroides duby for preventing or treating non-alcoholic fatty liver disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269402A (en) * 1999-04-01 2000-10-11 宋栋梁 Chiense herbal medicine wine
KR20050023191A (en) * 2003-08-27 2005-03-09 학교법인 한림대학교 Composition comprising extract from lysimachiae herba for preventing and treating arteriosclerosis and enhancement of immunity
CN1628845A (en) * 2003-12-17 2005-06-22 昆明紫健生物技术有限公司 Compound medicinal formulation with bioactivity
CN101199563A (en) * 2007-12-14 2008-06-18 苏州大学 Loosestrife total saponine anti-tumor function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100358530C (en) * 2004-11-11 2008-01-02 云南白药集团股份有限公司 Medicine prepn for treating cerebral apoplexy and its prepn

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269402A (en) * 1999-04-01 2000-10-11 宋栋梁 Chiense herbal medicine wine
KR20050023191A (en) * 2003-08-27 2005-03-09 학교법인 한림대학교 Composition comprising extract from lysimachiae herba for preventing and treating arteriosclerosis and enhancement of immunity
CN1628845A (en) * 2003-12-17 2005-06-22 昆明紫健生物技术有限公司 Compound medicinal formulation with bioactivity
CN101199563A (en) * 2007-12-14 2008-06-18 苏州大学 Loosestrife total saponine anti-tumor function

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE TCM [online] SIPO; 11 October 2000 (2000-10-11), SONG DONGLIANG, XP002617545, Database accession no. CN1269402 *
DATABASE TCM [online] SIPO; 22 June 2005 (2005-06-22), KUNMING ZIJIAN BIOTECHNOLOGY CO. LTD, XP002617544, Database accession no. CN1628845 *
DATABASE WPI Week 200559, Derwent World Patents Index; AN 2005-579271, XP002617551 *
DATABASE WPI Week 200868, Derwent World Patents Index; AN 2008-L53980, XP002617543 *

Also Published As

Publication number Publication date
WO2009091121A3 (en) 2009-09-03
KR100948332B1 (en) 2010-03-17
CN101969969A (en) 2011-02-09
EP2240191A2 (en) 2010-10-20
KR20090079650A (en) 2009-07-22
WO2009091121A2 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
EP2542060A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES
PL2546253T3 (en) Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases
EP2273882A4 (en) BIOACTIVE COMPOUNDS FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES
EP2391344A4 (en) COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN
EP2118074A4 (en) COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
EP2176283A4 (en) METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
EP2427061A4 (en) GALLIUM FORMULATION FOR THE TREATMENT AND PREVENTION OF INFECTIOUS DISEASES
EP2512240A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF TRIGEMINO-AUTONOMIC CEPHALES, MIGRAINS AND VASCULAR DISEASES
EP2419114A4 (en) BACTERIAL COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF DEGENERATIVE DISEASES
EP2118300A4 (en) PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGEN DISEASES
EP2322221A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CANCER
EP1804761A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DYSCHROMY
EP2046349A4 (en) TREATMENT OF EXCESSIVE NEOVASCULARIZATION
EP2493497A4 (en) INHIBITION OF NOTCH FOR THE TREATMENT AND PREVENTION OF OBESITY AND METABOLIC SYNDROME
EP2217238A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROTEIN DISEASES
EP2515926A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOGENESIS-RELATED OPHTHALMIC DISEASES
EP2249789A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF XEROSOMY
EP2429517A4 (en) APPROPRIATE COMPOSITIONS FOR THE TOPIC TREATMENT OF FUNGAL INFECTIONS OF SKIN AND NAILS
EP2240193A4 (en) Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases
EP2240191A4 (en) COMPOSITION COMPRISING LYSIMACHIA CLETHROID EXTRACTS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
EP2040726A4 (en) Trachelospermi caulis extract composition for the treatment and prevention of inflammatory diseases
EP2001488A4 (en) PREVENTION AND TREATMENT OF CANCERS AND OTHER DISEASES
FR2882654B1 (en) USE OF DIOSMETIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF THROMBOTIC DISEASES
EP2327402A4 (en) COMPOSITION COMPRISING 4-O-METHYLHONOKIOL FOR TREATING OR PREVENTING AMYLOID-RELATED DISEASES
EP1971354A4 (en) LIQUIRITIGENIN-BASED COMPOSITION FOR THE PREVENTION AND TREATMENT OF HEPATIC DISEASES

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100804

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RHEE, CHUNG KEUN

Inventor name: LIM, JEE WOONG

Inventor name: KIM, JONG-HOON

Inventor name: SOHN, JUNG-DUK

Inventor name: CHOI, WOON-SUN

Inventor name: LEE, JUNG-OK

Inventor name: OAK, MIN-HO

A4 Supplementary search report drawn up and despatched

Effective date: 20110314

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111011